drugset / Trial / NCT01622504
Naloxone Nasal Spray Pharmacokinetic Study
RandomizedCrossoverOpen-labelTreatment
Summary
This study aims to compare the pharmacokinetics of naloxone when administered as the Mitovie nasal spray (Test Product) and as a solution for injection (Comparator Product) administered intranasally using a mucosal atomization device (MAD).
Timeline
- Start
- 2012-06
- Primary completion
- 2012-07
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MVP005 | Unknown | 2 mg | Intranasal |
| Subject | MVP005 | Unknown | 4 mg | Intranasal |
| Comparator | Naloxone | Small molecule | 2 mg | Intranasal |